Our vision
is to offer first in-line treatment & protection against vision loss in degenerative eye disorders
Who we are
RetiPharma is a Danish Biotech company that is developing products for treatment of degenerative eye disorders based on peptides that exerts neuroprotective effect in the eye.
RetiPharma has developed a translational platform for drug development with the first new peptide drug RP001 being prepared for clinical study in patients with retinal detachment
